Quinalizarin
SIGMA/Q2763 - ≥95% (HPLC)
Synonym: 1,2,5,8-
CAS Number: 81-61-8
Empirical Formula (Hill Notation): C14H8O6
Molecular Weight: 272.21
EC Number: 201-366-6
MDL Number: MFCD00001205
Linear Formula: C14H8O6
Product Type: Chemical
| assay | ≥95% (HPLC) |
| color | red |
| form | powder |
| InChI | 1S/C14H8O6/c15-6-3-4-7(16 |
| InChI key | VBHKTXLEJZIDJF-UHFFFAOYSA |
| mp | ≥300 °C |
| Quality Level | 100 ![]() |
| SMILES string | Oc1ccc2C(=O)c3c(O)ccc(O)c |
| storage temp. | room temp |
| Application: | Quinalizarin has been used: • as a casein kinase II (CKII) inhibitor to study its effect on CKII-mediated phosphorylation of importin α on subcellular scaling in sperm chromosomes and egg extract • as a CKII inhibitor to study its ability to block parasite multiplication in a [3H]-hypoxanthine incorporation assay • to study its effect on colorectal cancer (CRC) cell cycle arrest, cell apoptosis, and reactive oxygen species (ROS) generation in SW480 and HCT-116 cell lines |
| Biochem/physiol Actions: | Quinalizarin is a potent (IC50 = 110 nM), ATP-competitive, and highly selective (IC50 >1μM against CK1 and 72 other kinases) casein Kinase II (CK2) inhibitor. |
| Biochem/physiol Actions: | Quinalizarin is a potent, ATP-competitive, and highly selective casein Kinase II (CK2) inhibitor. |
| Biochem/physiol Actions: | Studies show that quinalizarin can prevent the in vitro activity of recombinant Plasmodium falciparum casein kinase 2α (PfCK2α) catalytic subunit with an IC50 of 2μM. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | ![]() GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H302 - H400 |
| Precautionary statements | P264 - P270 - P273 - P301 + P312 - P391 - P501 |
| Hazard Codes | Xn,N |
| Risk Statements | 22-50 |
| Safety Statements | 61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Purity | ≥95% (HPLC) |
| mp | ≥300 °C |
| Storage Temp. | room temp |
| Colour Index Number | 58500 |
| UNSPSC | 12171500 |



